InsidersTradesSigma
Track the 健民集团 share price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 健民集团 has logged 7 public disclosures. Market capitalisation: €4.3bn. The latest transaction was reported on 4 April 2023 (Sale). Among the most active insiders: 黄芳晶父亲. The full history is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€3,374
1 ops.
Buy Volume
€34,966
6 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,399 of 29,063 companies
72.3
score / 100
Value69
Quality76
FCF yld4.1%
Earn yld8.4%
EV/EBITDA9.8x
ROE13%
Gross mgn58%
Net mgn11%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 April 2023
Declarations7 total
7 of 7 declarations
关于 健民集团
健民集团是一家健康医药领域的公司，在上海证券交易所上市。它专注于药品的研发和生产。